3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase EARLY_PHASE1
1
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
33
Breast Neoplasms
25
Rectal Neoplasms
23
Esophageal Neoplasms
22
Stomach Neoplasms
19
Squamous Cell Carcinoma of Head and Neck
18
Glioblastoma
16
Pancreatic Neoplasms
14
Lung Neoplasms
14
Head and Neck Neoplasms
12
Colorectal Neoplasms
11
Brain Neoplasms
10
Sarcoma
9
Neoplasms
9
Colonic Neoplasms
8
Adenocarcinoma Of Esophagus
7
Melanoma
6
Glioma
6
Esophageal Squamous Cell Carcinoma
6
Ovarian Neoplasms
5
Oropharyngeal Neoplasms
5
Hypopharyngeal Neoplasms
5
Carcinoma, Ovarian Epithelial
5
Adenocarcinoma of Lung
5
Prostatic Neoplasms
4
Mouth Neoplasms
4
Gliosarcoma
4
Fallopian Tube Neoplasms
4
Central Nervous System Neoplasms
4
Carcinoma, Squamous Cell
4
Interventions
HhAntag691
15
sonidegib
5
cemiplimab
5
Nivolumab
5
Aminolevulinic Acid
5
daromun
4
Specimen Handling
4
Radiotherapy
3
Magnetic Resonance Spectroscopy
3
3-ingenyl angelate
3
tazarotene
2
relatlimab
2
Ipilimumab
2
IPI-926
2
Drug Evaluation
2
Celecoxib
2
Biopsy
2
talimogene laherparepvec
1
remetinostat
1
gusacitinib
1
endonuclease V, phage T4
1
X-Rays
1
Triamcinolone
1
Sutures
1
Surgical Procedures, Operative
1
Solutions
1
Papillomavirus Vaccines
1
Opdualag
1
Observation
1
Niacinamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Carcinoma, Basal Cell
×
Surgical Procedures, Operative
×
Clear all
NCT03534947
2025-12-16
SONIB
Melanoma Institute Australia
Phase 2
Completed
16 enrolled